immunologic control of malignancy has helped establish escape from immunosurveillance as a critical requirelknt for incipient lktastases. Our improved understanding of the immune system's interactions with cancer cells has led to major therapeutic advances but has also unraveled a previously unsuspected level of complexity. This review will
immunologic control of malignancy has helped establish escape from immunosurveillance as a critical requirelknt for incipient lktastases. Our improved understanding of the immune system's interactions with cancer cells has led to major therapeutic advances but has also unraveled a previously unsuspected level of complexity. This review will